The application of cancer stem cell model in malignant mesothelioma

被引：4
作者：
Bronte, Giuseppe [1 ,4 ]
Procopio, Antonio Domenico [1 ,2 ]
Graciotti, Laura [3 ]
机构：
[1] Univ Politecn Marche, Dept Clin & Mol Sci DISCLIMO, Ancona, Italy
[2] Natl Inst Hlth & Sci Ageing INRCA IRCCS, Clin Lab & Precis Med, Ancona, Italy
[3] Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy
[4] Univ Politecn Marche, Dept Clin & Mol Sci DISCLIMO, Via Tronto 10-A, Ancona, Italy
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2022年 / 174卷
关键词：
Malignant mesothelioma; Cancer stem cells; Chemoresistance; PLEURAL MESOTHELIOMA; IDENTIFICATION; RESISTANCE; MUTATIONS; CISPLATIN; ASBESTOS; THERAPY; MARKERS; TARGET; BAP1;
D O I：
10.1016/j.critrevonc.2022.103698
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The high mortality rate of malignant pleural mesothelioma led to study the mechanisms for chemoresistance. The cancer stem cell (CSC) model has been proposed to explain chemoresistance. CSCs are characterized by self-renewal capacity, that is detected through tumor-initiating cell assays. As in other malignancies, many studies sought to identify surface markers to isolate CSCs from malignant mesothelioma. Other studies characterized malignant mesothelioma CSCs for the expression of specific genes involved in stemness and the expression of proteins involved in chemoresistance. However, the main methods to characterize isolated CSCs include sphere formation, invasiveness, tumor-initiating capacity and expression of specific surface markers. The better knowledge of malignant mesothelioma CSCs allowed exploring new potential targets to develop specific treatments.
引用
收藏
页数：7
相关论文
共 53 条
[41]   BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene x environment interaction with asbestos [J].
Novelli, Flavia ;
Bononi, Angela ;
Wang, Qian ;
Bai, Fang ;
Patergnani, Simone ;
Kricek, Franz ;
Haglund, Ellinor ;
Suarez, Joelle S. ;
Tanji, Mika ;
Xu, Ronghui ;
Takanishi, Yasutaka ;
Minaai, Michael ;
Pastorino, Sandra ;
Morris, Paul ;
Sakamoto, Greg ;
Pass, Harvey, I ;
Barbour, Haithem ;
Gaudino, Giovanni ;
Giorgi, Carlotta ;
Pinton, Paolo ;
Onuchic, Jose N. ;
Yang, Haining ;
Carbone, Michele .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (48)
[42]   Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways [J].
Ohno, Yoshiya ;
Shingyoku, Serina ;
Miyake, Sakina ;
Tanaka, Aya ;
Fudesaka, Sena ;
Shimizu, Yuta ;
Yoshifuji, Ai ;
Yamawaki, Yuki ;
Yoshida, Sachiyo ;
Tanaka, Saya ;
Sakura, Kazuma ;
Tanaka, Toshiyuki .
ONCOGENE, 2018, 37 (49) :6357-6367
[43]   Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents [J].
Pasdar, Elham Alizadeh ;
Smits, Michael ;
Stapelberg, Michael ;
Bajzikova, Martina ;
Stantic, Marina ;
Goodwin, Jacob ;
Yan, Bing ;
Stursa, Jan ;
Kovarova, Jaromira ;
Sachaphibulkij, Karishma ;
Bezawork-Geleta, Ayenachew ;
Sobol, Margaryta ;
Filimonenko, Anatoly ;
Tomasetti, Marco ;
Zobalova, Renata ;
Hozak, Pavel ;
Dong, Lan-Feng ;
Neuzil, Jiri .
PLOS ONE, 2015, 10 (05)
[44]   Role of Merlin/NF2 inactivation in tumor biology [J].
Petrilli, A. M. ;
Fernandez-Valle, C. .
ONCOGENE, 2016, 35 (05) :537-548
[45]  
PIERCE GB, 1988, CANCER RES, V48, P1996
[46]  
Surveillance Epidemiology and End Results (SEER) Program, 2021, SEER STAT DAT MORT A
[47]   A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma [J].
Tagliamento, Marco ;
Bironzo, Paolo ;
Curcio, Hubert ;
De Luca, Emmanuele ;
Pignataro, Daniele ;
Rapetti, Simonetta G. ;
Audisio, Marco ;
Bertaglia, Valentina ;
Paratore, Chiara ;
Bungaro, Maristella ;
Olmetto, Emanuela ;
Artusio, Elisa ;
Reale, Maria Lucia ;
Zichi, Clizia ;
Capelletto, Enrica ;
Carnio, Simona ;
Buffoni, Lucio ;
Passiglia, Francesco ;
Novello, Silvia ;
Scagliott, Giorgio Vittorio ;
Mai, Massimo Di .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 172
[48]   Germline BAP1 mutations predispose to malignant mesothelioma [J].
Testa, Joseph R. ;
Cheung, Mitchell ;
Pei, Jianming ;
Below, Jennifer E. ;
Tan, Yinfei ;
Sementino, Eleonora ;
Cox, Nancy J. ;
Dogan, A. Umran ;
Pass, Harvey I. ;
Trusa, Sandra ;
Hesdorffer, Mary ;
Nasu, Masaki ;
Powers, Amy ;
Rivera, Zeyana ;
Comertpay, Sabahattin ;
Tanji, Mika ;
Gaudino, Giovanni ;
Yang, Haining ;
Carbone, Michele .
NATURE GENETICS, 2011, 43 (10) :1022-U140
[49]  
van Kooten J.P., 2022, THORAX THORAXJNL, V2021
[50]   Multipotent Cancer Stem Cells Derived from Human Malignant Peritoneal Mesothelioma Promote Tumorigenesis [J].
Varghese, Sheelu ;
Whipple, Rebecca ;
Martin, Stuart S. ;
Alexander, H. Richard .
PLOS ONE, 2012, 7 (12)
123456